CONTACTStaffCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2023 Pride Publishing Inc.
All Rights reserved
All Rights reserved
Scroll To Top
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Biotechnology company Gilead Sciences Inc. on Thursday announced it had received a subpoena from the U.S. Department of Justice related to its marketing and medical education programs for three of its anti-HIV medications.
Gilead issued a statement saying the subpoena requested documents for its medications Truvada, Viread, and Emtriva. Company officials said they intended to comply with the subpoena, which came from the U.S. Attorney's office in San Francisco, and cooperate in any related government investigation. (Reuters)
From our Sponsors
Most Popular
Watch Now: Advocate Channel
Trending Stories & News
For more news and videos on advocatechannel.com, click here.
Trending Stories & News
For more news and videos on advocatechannel.com, click here.